IASLC Tobacco Declaration: IASLC Statement on Tobacco Control and Smoking Cessation (English, Chinese, Japanese, Polish, Portuguese, Spanish)-Tobacco Declaration: Declaración de IASLC - Dejar de Fumar Tras un Diagnóstico de Cáncer

Tobacco Declaration: Declaración de IASLC - Dejar de Fumar Tras un Diagnóstico de Cáncer - Spanish

Pdf Summary

The International Association for the Study of Lung Cancer (IASLC) has issued a statement emphasizing the importance of quitting smoking after a cancer diagnosis. Despite the well-known harms of smoking, the negative impacts of continuing to smoke post-diagnosis are often underestimated. Patients who continue smoking after a cancer diagnosis experience increased mortality rates, higher risks of secondary primary cancer, and greater toxicity from cancer treatments. However, many cancer patients do not quit smoking upon diagnosis, and healthcare providers often do not proactively assist them in quitting. The IASLC recommends several measures to address smoking in cancer patients, including routine screening for smoking status, providing evidence-based smoking cessation support, integrating smoking cessation into multidisciplinary cancer care, incorporating smoking cessation education into cancer control programs, reimbursing for smoking cessation services, and including smoking status as mandatory data in clinical studies. By addressing smoking cessation early and actively, healthcare providers can potentially help more cancer patients quit smoking and improve treatment outcomes.

Keywords

International Association for the Study of Lung Cancer

IASLC

quitting smoking

cancer diagnosis

mortality rates

secondary primary cancer

toxicity from cancer treatments

smoking cessation support

multidisciplinary cancer care

smoking status screening